The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials

BACKGROUND: Vortioxetine is an investigational multimodal antidepressant. We conducted this meta-analysis to assess the efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder (MDD). METHODS: Randomized controlled trials (RCTs) published in PubMed, Web of Science, Emb...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuropsychiatr Dis Treat
Hlavní autoři: Li, Guangjian, Wang, Xu, Ma, Dihui
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2016
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4778778/
https://ncbi.nlm.nih.gov/pubmed/27013879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S103173
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky